Pentavalent rotavirus vaccine bovine reassortant - Serum Institute of India
Alternative Names: BRV-PV; LBRV-PV; Live attenuated bovine-human reassortant rotavirus vaccine; Rota-V-Aid™; ROTASIIL®Latest Information Update: 26 Mar 2025
At a glance
- Originator Serum Institute of India
- Developer Pharm Aid; Serum Institute of India
- Class Rotavirus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Rotavirus infections
Most Recent Events
- 17 Mar 2025 PATH plans a phase II trial for Malaria (Prevention) in Burkina Faso (IM) (NCT06879327)
- 22 Feb 2019 Phase-III clinical trials in Rotavirus infections (In infants, Prevention) in Russia (PO) (NCT05032391)
- 28 Sep 2018 Launched for Rotavirus infections (In infants, Prevention) in India (PO) before September 2018